[Minimal change nephropathy and IgA deposits associated with a Sezary syndrome]

Rev Med Interne. 2022 Jan;43(1):48-53. doi: 10.1016/j.revmed.2021.08.006. Epub 2021 Aug 19.
[Article in French]

Abstract

Introduction: The Sézary syndrome (SS) is an aggressive form of cutaneous T-cell lymphoma (CTCL) requiring a rapid diagnosis due to its poor prognosis.

Case report: We report the first case of an eighty-nine-year-old woman who presented with concomitant Sezary syndrome and anasarca, revealing a nephrotic syndrome caused by a minimal change nephropathy associated with immunoglobulin A (IgA) deposits. Scarce literature described rare cases associating these two entities (nephrotic syndrome and nephropathy). However, the nephrotic syndrome was delayed from disease onset, secondary to immunosuppressive treatment of SS, or due to the weaning of SS therapy. Thus, the direct link between the glomerular lesion and the cutaneous lymphoma was difficult to establish. However, the synchronous occurrence of both SS and glomerulopathy in our patient, along with Sezary cells in both urines (urinary cytology) and biopsy, and resolution of nephropathy after treatment of SS, support the likely attributability of SS in glomerulopathy.

Conclusion: Practitioners must acknowledge the possible occurrence of glomerular involvement in SS.

Keywords: CTCL; Cutaneous T-cell lymphoma; IgA nephropathy; Lymphome T cutané; Lésions glomérulaires minimes; Minimal change nephropathy; Nephrotic syndrome; Néphropathie à IgA; Syndrome de Sézary; Syndrome néphrotique; Sézary syndrome.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Female
  • Glomerulonephritis, IGA* / complications
  • Glomerulonephritis, IGA* / diagnosis
  • Humans
  • Immunoglobulin A
  • Nephrosis, Lipoid* / complications
  • Nephrosis, Lipoid* / diagnosis
  • Nephrotic Syndrome* / complications
  • Nephrotic Syndrome* / diagnosis
  • Sezary Syndrome* / complications
  • Sezary Syndrome* / diagnosis
  • Skin Neoplasms* / complications
  • Skin Neoplasms* / diagnosis

Substances

  • Immunoglobulin A